Investigates ligand design to enhance inhibition of human peroxiredoxin 5, suggesting new therapeutic strategies.
High Resolution Image Download MS PowerPoint Slide Using insights from funnel metadynamics, a molecular dynamics protocol that provides a detailed representation of protein–ligand interactions, we investigated how a single heavy-atom modification can enhance the activity of an initial hit against human peroxiredoxin 5. This improvement was validated by NMR experiments and enzyme-inhibition assays. Our results illustrate how molecular dynamics simulations offer a rational framework for designing ligands with improved properties, starting from low affinity but selective hits with minimal structural modifications.
No takes yet. Share an insight, caveat, or question.
Troussicot et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: